A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Clinical trial NCT07527910 · RECRUITING

Trial details

NCT number: NCT07527910
Sponsor: Regeneron Pharmaceuticals
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Start date: 2026-05-22
Primary completion: 2030-03-15
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.